These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10521821)

  • 1. A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories.
    Sancken U; Bartels I; Louwen F; Eiben B
    Prenat Diagn; 1999 Oct; 19(10):947-54. PubMed ID: 10521821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
    Leporrier N; Herrou M; Herlicoviez M; Leymarie P
    Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
    Hu Z; Liu X; Li L; Jia C; Li D; Liu R
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
    Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
    Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
    Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
    Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
    Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
    Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of free beta-hCG in antenatal screening for Down's syndrome.
    Wald N; Densem J; Stone R; Cheng R
    Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
    Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
    Zeitune M; Aitken DA; Crossley JA; Yates JR; Cooke A; Ferguson-Smith MA
    Prenat Diagn; 1991 Nov; 11(11):847-57. PubMed ID: 1721713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of triple-risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free beta-subunit (free beta hCG).
    Sancken U; Bahner D
    Fetal Diagn Ther; 2003; 18(2):122-7. PubMed ID: 12576748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific beta1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18.
    Bersinger NA; Leporrier N; Herrou M; Leymarie P
    Prenat Diagn; 1999 Jun; 19(6):537-41. PubMed ID: 10416969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester.
    Xu D; Zhu Y; Li L; Xu Y; Yan W; Dai M; Gan L
    Front Genet; 2020; 11():497264. PubMed ID: 33574829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
    Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA
    Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate biochemical parameters in first-trimester screening for Down syndrome.
    Cuckle HS; van Lith JM
    Prenat Diagn; 1999 Jun; 19(6):505-12. PubMed ID: 10416963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
    Saller DN; Canick JA; Blitzer MG; Palomaki GE; Schwartz S; Blakemore KJ; Haddow JE
    Prenat Diagn; 1999 Sep; 19(9):813-6. PubMed ID: 10521837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
    Spencer K; Cowans NJ
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.